Literature DB >> 34140663

Isometric handgrip exercise training reduces resting systolic blood pressure but does not interfere with diastolic blood pressure and heart rate variability in hypertensive subjects: a systematic review and meta-analysis of randomized clinical trials.

João Pedro Arantes de Sousa Almeida1, Murilo Bessa1, Leandro Teixeira Paranhos Lopes2, Alexandre Gonçalves1, Leonardo Roever3, Hugo Ribeiro Zanetti4,5.   

Abstract

To evaluate the effects of isometric handgrip exercise training (IHET) on blood pressure and heart rate variability in hypertensive subjects. Five databases were searched for randomized clinical trials in English, Spanish, or Portuguese evaluating the effect of IHET vs. no exercise on blood pressure (systolic and/or diastolic) and/or heart rate variability (low frequency [LF], high frequency [HF], and/or LF/HF ratio) through December 2020. Random-effects meta-analyses of mean differences (MDs) and/or standardized mean differences (SMDs) with 95% confidence intervals (CIs) were performed. Five trials were selected (n = 324 hypertensive subjects), whose durations ranged from 8 to 10 weeks. Compared to no exercise, IHET reduced systolic blood pressure (MD -8.11 mmHg, 95% CI -11.7 to -4.53, p < 0.001) but did not affect diastolic blood pressure (MD -2.75 mmHg, 95% CI -9.47-3.96, p = 0.42), LF (SMD -0.14, 95% CI -0.65-0.37, p = 0.59), HF (SMD 0.38, 95% CI -0.14-0.89, p = 0.15), or the LF/HF ratio (SMD -0.22, 95% CI -0.95-0.52, p = 0.57). IHET performed for 8-10 weeks had a positive effect on resting systolic blood pressure but did not interfere with diastolic blood pressure or heart rate variability in hypertensive subjects. These data should be interpreted with caution since all volunteers included in the studies were clinically medicated and their blood pressure was controlled.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Blood pressure; Heart rate variability; Hypertension; Isometric exercise

Mesh:

Year:  2021        PMID: 34140663     DOI: 10.1038/s41440-021-00681-7

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  36 in total

Review 1.  Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology.

Authors:  Janice K Kiecolt-Glaser; Lynanne McGuire; Theodore F Robles; Ronald Glaser
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

Review 2.  Effects of isometric handgrip training on cardiac autonomic profile: A systematic review and meta-analysis study.

Authors:  Breno Q Farah; Diego G D Christofaro; Marilia A Correia; Crystian B Oliveira; Belinda J Parmenter; Raphael M Ritti-Dias
Journal:  Clin Physiol Funct Imaging       Date:  2020-02-05       Impact factor: 2.273

3.  Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.

Authors:  H Tsuji; F J Venditti; E S Manders; J C Evans; M G Larson; C L Feldman; D Levy
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

4.  Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Véronique A Cornelissen; Robert H Fagard
Journal:  J Hypertens       Date:  2005-02       Impact factor: 4.844

5.  Effects of isometric handgrip training among people medicated for hypertension: a multilevel analysis.

Authors:  Philip J Millar; Steve R Bray; Cheri L McGowan; Maureen J MacDonald; Neil McCartney
Journal:  Blood Press Monit       Date:  2007-10       Impact factor: 1.444

6.  The hypotensive effects of isometric handgrip training using an inexpensive spring handgrip training device.

Authors:  Philip J Millar; Steven R Bray; Maureen J MacDonald; Neil McCartney
Journal:  J Cardiopulm Rehabil Prev       Date:  2008 May-Jun       Impact factor: 2.081

Review 7.  The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors.

Authors:  Julian F Thayer; Shelby S Yamamoto; Jos F Brosschot
Journal:  Int J Cardiol       Date:  2009-11-11       Impact factor: 4.164

8.  How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.

Authors:  Huseyin Naci; Maximilian Salcher-Konrad; Sofia Dias; Manuel R Blum; Samali Anova Sahoo; David Nunan; John P A Ioannidis
Journal:  Br J Sports Med       Date:  2018-12-18       Impact factor: 13.800

Review 9.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.

Authors:  Gregory A Roth; George A Mensah; Catherine O Johnson; Giovanni Addolorato; Enrico Ammirati; Larry M Baddour; Noël C Barengo; Andrea Z Beaton; Emelia J Benjamin; Catherine P Benziger; Aimé Bonny; Michael Brauer; Marianne Brodmann; Thomas J Cahill; Jonathan Carapetis; Alberico L Catapano; Sumeet S Chugh; Leslie T Cooper; Josef Coresh; Michael Criqui; Nicole DeCleene; Kim A Eagle; Sophia Emmons-Bell; Valery L Feigin; Joaquim Fernández-Solà; Gerry Fowkes; Emmanuela Gakidou; Scott M Grundy; Feng J He; George Howard; Frank Hu; Lesley Inker; Ganesan Karthikeyan; Nicholas Kassebaum; Walter Koroshetz; Carl Lavie; Donald Lloyd-Jones; Hong S Lu; Antonio Mirijello; Awoke Misganaw Temesgen; Ali Mokdad; Andrew E Moran; Paul Muntner; Jagat Narula; Bruce Neal; Mpiko Ntsekhe; Glaucia Moraes de Oliveira; Catherine Otto; Mayowa Owolabi; Michael Pratt; Sanjay Rajagopalan; Marissa Reitsma; Antonio Luiz P Ribeiro; Nancy Rigotti; Anthony Rodgers; Craig Sable; Saate Shakil; Karen Sliwa-Hahnle; Benjamin Stark; Johan Sundström; Patrick Timpel; Imad M Tleyjeh; Marco Valgimigli; Theo Vos; Paul K Whelton; Magdi Yacoub; Liesl Zuhlke; Christopher Murray; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2020-12-22       Impact factor: 24.094

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.